Skip to content

Swiss Open Innovation Webinar

Life sciences

20 May 2021

Innovation and digital health in Western Switzerland

Digital health lies at the crossroads of multiple industries: it is defined as the use of information and communication technologies to improve health and health services. Known as the home of major pharma companies, Switzerland is also very active in digital health, with a dense ecosystem bridging research and innovation.

This webinar, organized in partnership with JETRO Geneva and the Service of the Economy of the Canton of Neuchâtel, will present the digital health ecosystem in Western Switzerland, as well as three start-ups with promising technologies in cancer prevention, care for the elderly and apnea diagnosis.

Date/Time: 16 February 2022, 17:00-18:15 (JST), 09:00-10:15 (CET)

Target audience: Japanese companies looking to collaborate with Swiss start-ups and research centers (other interested companies are also welcome to join)

Participation: Free of charge, but limited to 100 persons

Language: Japanese/English (simultaneous translation available)

Program and registration

Participating organizations and companies:

CSEM is a private nonprofit Swiss organization for research and innovation. Supported by the Swiss Confederation, our mission is to enhance the competitiveness of industry by developing new technology platforms and transferring it to the industrial sector. CSEM plays a key role in the innovation value chain, by narrowing the gap between fundamental research and industrialization. By expanding CSEM’s knowledge and adapting it to industrial needs, new products are brought to market and new ventures are created. CSEM works with a wide range of stakeholders, from start-ups to SMEs and large organizations CSEM‘s services include contract R&D, strategy and innovation consultancy, development of specific business solutions for several Industrial Sectors (Space & Scientific Instrumentation, Watchmaking, Health & Lifestyle, Communication & Semiconductor, Energy & Environment, Automation & Control, Aeronautics, Transport & Security).

Microcity’s mission is to stimulate, support, accelerate and promote the realization of innovation projects. Microcity promotes skills in research, development, technology transfer and industrialization. The company provides specialized resources in the fields of business consulting, hosting, financing and communication, particularly in the fields of micro-nanotechnologies, micro-manufacturing and industrialization processes.

NetSensing Technology is a Swiss medtech startup, founded in 2019 which has patented a methodology to enable the mass detection of sleep apnea. This methodology is fully compliant with the American Academy of Sleep Medicine (AASM). The main objective is to save lives by enabling the mass detection of sleep disorders faster and cheaper than any other method. The technology is based on data fusion collected by dedicated sensors. The device directly measures thorax and diaphragm respirations, body posture, heart rate and oxygen saturation and, correlates them to detect apnea severity. The Apnea Hypopnea Index (AHI) is available overnight, and HSATPro displays a green/red indicator for users on their smartphones/tablets to indicate apnea severity. In case of a red event, the data summary can be quickly delivered to pharmacies and doctors to enable treatment.

Icosamed‘s goal is to design, manufacture and sell garments to monitor resident cancers – especially breast cancer. More than 85% of cancers at stage 0 are not detected: if so, that could be easily fixed with very light treatments (surgery and low explore of radiation). Our goal is to reduce this number to 0% by monitoring and super-early detecting cancer. This total disruptive approach is using a proven technology (3D ultrasound), migrated to smart clothing. The smart bra EZ ROSE® is a wireless connected device, USB rechargeable, fully autonomous and piloted through an app. Data are sent to our servers via smartphone and images are rebuilt in 3D. Based on history and working with AI and big data, the system will warn the user on its smartphone if an evolution similar to a tumor cell growth is detected and statically confirmed. This is a unique approach for cancer monitoring, complementary and synergistic with existing one. This represents a tremendous hope for public health. Icosamed is a team of experts with multiple skills around micro technologies, digital health and marketing and communication.

MyElixa‘s vision is to be the trusted ally for healthy aging. MyElixa provides smart devices to holistically support senior people on their daily activities and provide the peace of mind to their family members and caregivers. The first product in our portfolio is focused on Hydration. MyElixa Hydration Band is flexible band that can be wrapped to any bottle or glass, measures how much you drink and reminds you to drink regularly. The data are sent real time to MyElixa App, used by family members. The product will be launched in Japan in May 2022 with pre-orders starting in March 2022 through a crowdfunding platform.